Patient (pt) population and radiation therapy (RT) type in the long-term phase 3 double-blind, placebo (PBO)-controlled ATLAS study of apalutamide (APA) added to androgen deprivati... von Sandler, Howard M., Freedland, Stephen J., Shore, Neal D., Smith, Matthew Raymond, Rosales, Rosamerlinda S., Brookman-May, Sabine D., Dearnaley, David P., Dicker, Adam P., McKenzie, Michael R., Bossi, Alberto, Widmark, Anders, Wiegel, Thomas, Martin, Jason L., Miladinovic, Branko, Whalen, Jennifer Anne, Ciprotti, Marika, McCarthy, Sharon, Mundle, Suneel, Tombal, Bertrand F., Feng, Felix Y

Volltext

Bioequivalence of 240 mg Apalutamide Tablets and Preparation in Aqueous Food Vehicles for Alternative Administration von Yu, Alex, Van Uffel, Mieke, Jiao, Juhui J., Rosales, Rosamerlinda, Erba, Maura, Haddish‐Berhane, Nahor

Volltext

Results of a Multi-Center, Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) von Foon, Kenneth, Allen, Steven, Sen, Kaushik, Mohrbacher, Ann, Sanani, Shamel, Lenaz, Luigi, Rosales, Rosamerlinda

Volltext

A Multi-Center, Open-Label, Non-Randomized Phase II Study of Elsamitrucin (SPI-28090) in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL) von Mohrbacher, Ann, Sanani, Shamel, Irwin, David, Espina, Byron M., Madrid, Catherine, Lenaz, Luigi, Rosales, Rosamerlinda

Volltext